Clinical Trials List
Protocol NumberM24-560
Not yet recruiting
2026-04-01 - 2029-11-30
Phase III
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 黃彥鈞 無
- 高冠鈞 無
- Jia-Ruey Tsai 無
Co-Principal Investigator
- Tzeon-jye Chiou 無
- Tzu-Yao Liao 無
- 林恩光 無
- 謝宛蓁 無
Co-Principal Investigator
- 蔡承志 無
- TSU-YI CHAO 無
- 莊博雅 無
- HUI-WEN LIU 無
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
700 participants
